MENU
+Compare
SGMO
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$2.33
Change
-$0.48 (-17.02%)
Capitalization
588.38M

SGMO Sangamo Therapeutics Forecast, Technical & Fundamental Analysis

a developer of transcription factors in the regulation of genes

Industry Biotechnology
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for SGMO with price predictions
Dec 17, 2024

Aroon Indicator for SGMO shows an upward move is likely

SGMO's Aroon Indicator triggered a bullish signal on November 19, 2024. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator showed a similar pattern. In of the 122 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 16, 2024. You may want to consider a long position or call options on SGMO as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SGMO just turned positive on December 16, 2024. Looking at past instances where SGMO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where SGMO advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SGMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SGMO broke above its upper Bollinger Band on December 16, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SGMO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.453) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). SGMO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (8.643) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SGMO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SGMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SGMO is expected to report earnings to fall 293.75% to -7 cents per share on February 19

Sangamo Therapeutics SGMO Stock Earnings Reports
Q4'24
Est.
$-0.08
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.03
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.08
The last earnings report on November 12 showed earnings per share of 3 cents, beating the estimate of -1 cents. With 9.93M shares outstanding, the current market capitalization sits at 588.38M.
A.I. Advisor
published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSTTX13.96N/A
N/A
Goldman Sachs Strategic Growth Inv
VIOAX9.72-0.02
-0.21%
VELA Income Opportunities A
NBPTX45.93-0.20
-0.43%
Neuberger Berman Large Cap Value Tr
JPVRX14.79-0.13
-0.87%
JPMorgan Developed International ValueR5
TRVRX17.92-0.25
-1.38%
Nuveen Mid Cap Value Retire

SGMO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMO has been loosely correlated with AXON. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMO
1D Price
Change %
SGMO100%
+6.62%
AXON - SGMO
51%
Loosely correlated
-2.09%
ARRY - SGMO
48%
Loosely correlated
+6.01%
BCRX - SGMO
46%
Loosely correlated
+0.40%
RPRX - SGMO
45%
Loosely correlated
+0.48%
AGEN - SGMO
43%
Loosely correlated
+4.42%
More